BACKGROUND: We previously found plasma levels of CD40 ligand (CD40L), chemokine (C-X-C motif) ligand 5 (CXCL5), chemokine (C-C motif) ligand 5 (CCL5) and epidermal growth factor (EGF) to be low in aplastic anemia (AA) patients and to be correlated with platelet count. OBJECTIVES: To study the association of CD40L, CXCL5, CCL5 and EGF with platelets. METHODS: We measured cytokines in the plasma of immune thrombocytopenic purpura (ITP) and AA patients using the Luminex assay and confirmed the results in a mouse model and in vitro experiments. RESULTS: Both ITP and AA showed similarly low levels of CD40L, CXCL5, CCL5 and EGF, compared with healthy controls. In ITP, levels of these proteins were significantly greater in patients with higher platelet counts than in those with lower platelet counts. In a murine thrombocytopenia model, levels of CD40L, CXCL5, CCL5 and EGF decreased with platelet count after immune-mediated destruction, while the cytokine levels increased when the platelet count recovered. In vitro, concentrations of these cytokines in the supernatants of platelet suspensions were proportional to platelet numbers, and levels in sera prepared by simple blood coagulation were equivalent to those in platelet-rich plasma-converted sera. mRNA expression for CXCL5, CCL5 and EGF was higher in platelets than in megakaryocytes, peripheral blood mononuclear cells, granulocytes and non-megakaryocytic bone marrow cells. CONCLUSIONS: Plasma CD40L, CXCL5, CCL5 and EGF are mainly platelet-derived, suggesting a role of platelets in immune responses and inflammation. Measurement of CD40L, CXCL5, CCL5 and EGF in human blood allowed testable inferences concerning physiology and pathophysiology in quantitative platelet disorders.
BACKGROUND: We previously found plasma levels of CD40 ligand (CD40L), chemokine (C-X-C motif) ligand 5 (CXCL5), chemokine (C-C motif) ligand 5 (CCL5) and epidermal growth factor (EGF) to be low in aplastic anemia (AA) patients and to be correlated with platelet count. OBJECTIVES: To study the association of CD40L, CXCL5, CCL5 and EGF with platelets. METHODS: We measured cytokines in the plasma of immune thrombocytopenic purpura (ITP) and AA patients using the Luminex assay and confirmed the results in a mouse model and in vitro experiments. RESULTS: Both ITP and AA showed similarly low levels of CD40L, CXCL5, CCL5 and EGF, compared with healthy controls. In ITP, levels of these proteins were significantly greater in patients with higher platelet counts than in those with lower platelet counts. In a murinethrombocytopenia model, levels of CD40L, CXCL5, CCL5 and EGF decreased with platelet count after immune-mediated destruction, while the cytokine levels increased when the platelet count recovered. In vitro, concentrations of these cytokines in the supernatants of platelet suspensions were proportional to platelet numbers, and levels in sera prepared by simple blood coagulation were equivalent to those in platelet-rich plasma-converted sera. mRNA expression for CXCL5, CCL5 and EGF was higher in platelets than in megakaryocytes, peripheral blood mononuclear cells, granulocytes and non-megakaryocytic bone marrow cells. CONCLUSIONS: Plasma CD40L, CXCL5, CCL5 and EGF are mainly platelet-derived, suggesting a role of platelets in immune responses and inflammation. Measurement of CD40L, CXCL5, CCL5 and EGF in human blood allowed testable inferences concerning physiology and pathophysiology in quantitative platelet disorders.
Authors: Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George Journal: Blood Date: 2008-11-12 Impact factor: 22.113
Authors: Xingmin Feng; Phillip Scheinberg; Colin O Wu; Leigh Samsel; Olga Nunez; Courtney Prince; Rebecca D Ganetzky; J Philip McCoy; Jaroslaw P Maciejewski; Neal S Young Journal: Haematologica Date: 2010-12-15 Impact factor: 9.941
Authors: A Solanilla; J Déchanet; A El Andaloussi; M Dupouy; F Godard; J Chabrol; P Charbord; J Reiffers; A T Nurden; B Weksler; J F Moreau; J Ripoche Journal: Blood Date: 2000-06-15 Impact factor: 22.113
Authors: Patrick André; K S Srinivasa Prasad; Cécile V Denis; Ming He; Jessie M Papalia; Richard O Hynes; David R Phillips; Denisa D Wagner Journal: Nat Med Date: 2002-03 Impact factor: 53.440
Authors: Gail E Kilroy; Sandra J Foster; Xiying Wu; Joseph Ruiz; Sonya Sherwood; Aaron Heifetz; John W Ludlow; Dawn M Stricker; Suma Potiny; Patrick Green; Yuan-Di C Halvorsen; Bentley Cheatham; Robert W Storms; Jeffrey M Gimble Journal: J Cell Physiol Date: 2007-09 Impact factor: 6.384
Authors: Desmond D Mascarenhas; Amina El Ayadi; Michael Wetzel; Anesh Prasai; Randy Mifflin; Jayson Jay; David N Herndon; Celeste C Finnerty Journal: Int J Burns Trauma Date: 2016-11-30
Authors: Verena Rolfes; Lucas Secchim Ribeiro; Ibrahim Hawwari; Lisa Böttcher; Nathalia Rosero; Salie Maasewerd; Marina Lima Silva Santos; Tomasz Próchnicki; Camila Meirelles de Souza Silva; Carlos Wagner de Souza Wanderley; Maximilian Rothe; Susanne V Schmidt; H James Stunden; Damien Bertheloot; Magali Noval Rivas; Cor Jesus Fontes; Luzia Helena Carvalho; Fernando Queiroz Cunha; Eicke Latz; Moshe Arditi; Bernardo Simoes Franklin Journal: Cell Rep Date: 2020-05-12 Impact factor: 9.423